Clinical Day programme

PDF icon Clinical Day Schedule

Friday, June 2, 2023

Location: St. James Club

Overall Program Objectives

  1. Identify and evaluate how artificial intelligence can transform the diagnosis and delivery of ophthalmology.
  2. Describe how new surgical interventions can fit in the paradigm of disease management.
  3. Examine novel medical treatments for ophthalmic pathologies.
  4. Discuss new operational techniques for improving the efficiency and efficacy of a clinic in delivering ophthalmic care.


7:30am Registration & Breakfast

8:30am Opening Remarks

Dr. Leonard Levin, MD, PhD, Chair, McGill Department of Ophthalmology and Visual Sciences (5mins)

Dr. Mahshad Darvish, MDCM, MBA, Chair, McGill Ophthalmology Clinical Day (5mins)

 Innovations in Diagnostics
Moderator: Dr. Fatma Zaguia

8:40am Dario Lorenzetti Lecture: From Pixels to Precision: Improving Glaucoma Diagnostics with AI – Dr. Felipe Medeiros

  • Discuss artificial intelligence applications to improve screening, diagnosis and detection of glaucoma progression
  • Analyze the current evidence regarding the role of AI, with discussion of limitations and biases


9:05am Stephen Fichman Lecture: AI Enhances Teleophthalmology for Diabetic Retinopathy Screening in Primary Care – Dr. Theodore Leng


  • Describe the challenges of performing population-wide diabetic retinopathy screening per the American Academy of Ophthalmology recommendations
  • Evaluate the impact of a distributed, AI-enabled network to screen for DR in an academic primary care network

9:30am AI & Precision Medicine in Ophthalmology - Ranya Habash

  • Understand the need for precision medicine in patient care
  • Understand the use of digital twinning in precision medicine

9:45am Sean B. Murphy Lecture: Rise of the Machines: Science Fiction/Science Fact

Dr. Ranya Habash

  • Review and explain new technologies in medicine
  • Understand the merits of brain-machine technology


10:10am BREAK

Surgical Innovations

Moderator: Dr. Michael Kapusta

11:00am Diffusion of Innovation - Dr. Mahshad Darvish

  • Distinguish the five main elements that influence the spread of a new idea
  • Describe the five stages of the process an individual goes through in adopting an innovation

11:15am  Artificial Corneas – Dr. Marie-Claude Robert

  • Discuss the unmet need for alternatives to corneal transplantation.
  • Describe potential complications of Boston keratoprosthesis implantation.
  • Identify theoretical advantages of cell-free biomaterial implants that allow for corneal regeneration.

11:30am Robotic-Assisted Vitreoretinal Surgery - Vincent Sun

  • Discuss current implementions of robotic assisted vitrectomy systems
  • Review pathology amenable to robotic assisted vitrecomy

11:45am Glaucoma Surgery Innovation: Do More Options Mean Better Options?

Dr. Hady Saheb

  • Compare the different categories of glaucoma surgery while discussing the recent innovations within each category
  • Explain the impact of glaucoma surgical innovations on our treatment decision-making

12:00pm Corneal Allogenic Intrastromal Ring Segments – Dr. Julia Talajic

  • Explain Corneal Allogenic Intrastromal Ring Segments
  • Review and explain the indications of CAIRS - where should they be considered in the keratoconus treatment algorithm?

12:15pm New Surgical Classification for Large Macular Holes Based on Most Recent Surgical Techniques – Dr. Flavio Rezende

  • Learn about the new classification for large macular holes
  • Learn about newer surgical techniques results for large macular holes

12:30pm LUNCH

Innovations in Therapeutics
Moderator: Dr. Karin Oliver

1:45pm Revolutionizing Glaucoma Management: The Promise of Sustained Drug Delivery Therapy – Dr. Felipe Medeiros

  • Review limitations of current available medical therapies for glaucoma and patient adherence
  • Discuss recent findings on the efficacy of sustained drug-delivery therapies for glaucoma, including findings from clinical trials. Discuss limitations and potential side-effects of currently available approved therapies.


    2:00pm Disarmingly Wild: Therapies to Slow Optic Neuropathy in Glaucoma
    Dr. Leonard Levin

    • Evaluate the importance of slowing or stopping axonal degeneration in optic nerve diseases, including glaucoma
    • Discuss how drugs can be developed to help protect axons from degenerating,

    2:30pm   Current and Upcoming Gene Therapy Treatments – Dr. Cynthia Qian

    • Explain the pathologies for which there is currently ongoing research or approved gene therapies
    • Discuss the general classes of mechanisms of action and target sites of current gene therapy treatments.

    2:45pm BREAK

    Operational Innovations in the Clinic

    Moderator: Dr. Daniella Toffoli

    3:15pm Operational Musings of a Clinician – Dr. Kashif Baig

    • Discuss emerging concepts in practice management
    • Evaluate resources that can be used to understand practice management

    3:40pm Applying LEAN Methodology to Clinic Flow to Reduce Wait Times

    Dr. Theodore Leng

    • Describe what can contribute to clinic wait times in a retinal practice
    • Evaluate the impact of distributed imaging and workflow re-configuration on wait times and total time in clinic

    4:05pm Medicine in the Metaverse – Dr. Ranya Habash

    • Evaluate the use cases for metaverse technology in healthcare
    • Explain how metaverse technology assists in surgical education
      4:20pm Concluding Panel Discussion
      Dr. Theodore Leng, Dr. Felipe Medeiros, Dr. Ranya Habash, Dr. Kashif Baig

    4:40pm Concluding Remarks

    4:45pm Closing of the Activity

    Guest Speakers

    Dr. Ranya Habash, MD

    Sean B. Murphy Lecturer

    Dr. Ranya Habash is a refractive cataract surgeon and comprehensive ophthalmologist with a unique background in the
    clinical, technical, and business sides of medicine. She was appointed to the FDA’s Digital Health Network of Experts and
    named to The Ophthalmologist Power List several times, including the top 50 stars in the world "who will lead
    ophthalmology over the next few decades and shape its future," then as one of the “most influential people in
    ophthalmology” worldwide. With experiences as CEO of LifeLong Vision, Visionary Innovation Mentor at Stanford
    University, and Medical Director of Technology at Bascom Palmer Eye Institute, her perspective grows further.

    Habash began her journey as Co-Founder of HipaaChat and Chief Medical Officer of Everbridge, a publicly traded global
    leader in critical communications. Everbridge acquired then integrated HipaaChat’s messaging and telemedicine platform,
    serving over 1500 health systems. As Chief Medical Officer, Habash collaborated with companies like Apple, Amazon, and
    Verizon to modernize communication for hospitals on a nationwide scale. As a result, she was named by Becker’s Hospital
    Review as a Top Healthcare Entrepreneur to Know. Her telehealth training and materials have been internationally
    embraced, and her work was cited in U.S. Senate Committee hearings for telehealth expansion in all medical specialties.

    Habash joined Microsoft’s healthcare team to lead a global machine learning initiative, delivering a multi-disease retinal
    algorithm to automate diagnosis and treatment of eye conditions. As program manager, she worked to build a global
    collaborative network for data sharing and digital health collaboration. Her Microsoft work set the stage for her current
    role as President of Digital Health for Avellino, where she is developing a large-scale data marketplace by merging
    genomics with predictive analytics for precision medicine.

    Most recently, Habash co-founded MetaMed, a metaverse platform for surgical training, education, and extended reality
    patient care. This remarkable background inspires her goals and the continued impact she hopes to make on healthcare.

    Dr. Theodore Leng, MD, MS  Stephen Fichman Lecturer

    Dr. Theodore Leng, MD, MS

    Stephen Fichman Lecturer

    Theodore Leng, MD, MS is an internationally recognized specialist in vitreoretinal diseases and surgery and has been
    named one of the top 150 innovators in the field of retina. He serves as the Director of Clinical and Translational Research
    at the Byers Eye Institute at the Stanford University School of Medicine Department of Ophthalmology in Palo Alto, CA,
    where he oversees more than 50 research programs. Dr. Leng attended the Stanford University School of Medicine for his MD
    and completed his ophthalmology residency at Bascom Palmer Eye Institute in Miami, FL.

    After a postdoctoral and clinical fellowship in vitreoretinal diseases and surgery at Stanford, Dr. Leng joined the faculty
    in the Department of Ophthalmology at Stanford and is an Associate Professor. He has published over 120 peer-reviewed
    manuscripts and serves as the Associate Editor for Ophthalmic Surgery Lasers and Imaging Retina.
    His current research interests include computer-aided and machine learning analysis of retinal images, cell-based therapies,
    clinical trials, multimodal imaging and real-world evidence.


    Dr. Felipe Medeiros, MD  Dario Lorenzetti Lecturer
    Dr. Felipe Medeiros, MD

    Dario Lorenzetti Lecturer

    Dr. Medeiros joined Duke Ophthalmology as Professor in August 2017. Prior to joining Duke, he was a full professor of ophthalmology
    the UCSD School of Medicine where he held the Ben and Wanda Hildyard Endowed Chair for Diseases of the Eye.
    He also served as medical director of the Hamilton Glaucoma Center,
    University of California San Diego and director of the Visual Performance Laboratory at UCSD.

    His research focuses on the development of innovative methods to diagnose and detect glaucoma progression as well
    as on the assessment and prevention of functional impairment in the disease, the leading cause of blindness in the world.
    In his research, Dr. Medeiros evaluates the impact of eye diseases on activities of daily living, using innovative techniques
    such as virtual reality. His laboratory was the first to use virtual reality to predict a clinically relevant functional outcome in medicine.
    He has also concentrated on developing innovative brain-computer interfaces for objective and portable assessment of
    visual function in several diseases. His research has been funded by numerous federal and private grants. He is the principal
    investigator on a National Institutes of Health(NIH) R01 to evaluate functional impairment in glaucoma and on an
    NIH R21 for development of a new method for assessing functional loss in glaucoma.

    He has been the recipient of numerous honors and awards. His research has been published in over 300 peer-reviewed publications
    including major ophthalmology journals, 40 book chapters and five books on the evaluation of the optic nerve,
    visual field, intraocular pressure, diagnosis and progression of glaucoma.


    This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and a recognized professional development and assessment activity (Categories A) as defined by the Collége des médecins du Quebec. This activity was approved by the direction de Développement professionnel continu (DDPC) of the Fédération des Médecins specialists due Québec.

    You may claim a maximum of 5.75 hours Section 1 / Recognized Professional Development Activity

    (Category A). Participants should claim a number of hours consistent with their attendance.

    CanMEDS Roles

    Number of Objectives Meeting Competency


    Expert Medical












    Health Promoter












    Le programme a été élaboré conjointement avec l’Association des médecins ophtalmologistes du Québec (AMOQ) de manière à respecter les principes d’intégrité, d’objectivité et d’équilibre scientifiques.

    Ce congrès scientifique est réservé aux ophtalmologistes, aux résidents en ophtalmologie et aux étudiants en médecine.

    Divulgation de conflits d’intérêts potentiels : Tout conflit d’intérêt sera divulgué par le comité scientifique, les conférencier.ère.s et les personnes ressources lors des présentations.

    L’AMOQ, par le biais de sa cotisation syndicale, participe au financement de la Journée clinique d’ophtalmologie de McGill.

    Énoncé de mission Comité DPC-AMOQ

    Le Comité du développement professionnel continue (DPC) de l’Association des médecins ophtalmologistes du Québec (AMOQ) s’est donné pour mandat d’assurer le maintien des connaissances professionnelles et d’améliorer les compétences transverses des membres de l’Association dans le but d’offrir à la population du Québec les meilleurs standards de qualité en ce qui a trait à la pratique de l’ophtalmologie.


    Back to top